Oss, Netherlands

Jos Cals


 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Jos Cals

Introduction

Jos Cals, an innovative inventor based in Oss, Netherlands, has made significant contributions to the field of pharmaceutical compounds. With a successful track record of 3 patents, his work focuses on advancing treatments for various medical conditions, particularly those mediated by RORgammaT.

Latest Patents

Among his latest innovations are two notable patents related to RORgammaT inhibitors. These inventions involve compounds described by specific formulas that can be utilized in treating diseases or conditions linked to RORgammaT. The compounds can be presented as pharmaceutically acceptable salts or solvates, highlighting their potential therapeutic applications.

Career Highlights

Throughout his career, Jos Cals has been associated with reputable organizations such as Merck Sharp & Dohme Corporation and Merck Sharp & Dohme B.V. His professional journey has enabled him to leverage his expertise in pharmaceutical research and development, driving forward innovations that address pressing medical needs.

Collaborations

In his pursuit of innovation, Jos has collaborated with esteemed colleagues, including Willem Frederik Johan Karstens and Mario Van Der Stelt. These partnerships have likely enriched his research efforts and contributed to the advancement of his patented technologies.

Conclusion

Jos Cals is a prolific inventor whose work in RORgammaT inhibitors illustrates the power of innovative thinking in addressing complex health challenges. His patents not only showcase his individual contributions but also reflect the collaborative nature of scientific advancement within the pharmaceutical industry. The ongoing exploration of his inventions promises potential breakthroughs in the treatment of RORgammaT-mediated diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…